MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Wang, Sheng Chun ^a   Lin, Xiao Lin ^a   Li, Jing ^a   Zhang, Ting Ting ^a   Wang, Hui Yan ^a   Shi, Jun Wen ^a   Yang, Sheng ^a   Zhao, Wen Tao ^a   Xie, Rao Ying ^a   Wei, Fang ^a   Qin, Yu Juan ^a   Chen, Lin ^a   Yang, Jie ^a   Yao, Kai Tai ^a   Xiao, Dong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BVES PROTEIN; CELL PROTEIN; FIBRONECTIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MICRORNA 122; MST4 PROTEIN; OCCLUDIN; PROTEIN ZO1; RHO ASSOCIATED PROTEIN KINASE 1; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; CADHERIN; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; MICRORNA; MIRN122 MICRORNA, HUMAN;

ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CARCINOMA CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL DISRUPTION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; MIR 122 GENE; PHENOTYPE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ALPHA CATENIN; BASE SEQUENCE; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; RHOA GTP-BINDING PROTEIN; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION; VIMENTIN;

EID: 84903778415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101330     Document Type: Article

References (51)

1. Jopling C (2012) Liver-specific microRNA-122: Biogenesis and function. RNA Biol 9: 137-142.
2. Hu J, Xu Y, Hao J, Wang S, Li C, et al. (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3: 364-371.
3. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A (2008) miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48: 648-656.
4. Lewis AP, Jopling CL (2010) Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans 38: 1553-1557.
5. Filipowicz W, Grosshans H (2011) The liver-specific microRNA miR-122: biology and therapeutic potential. Prog Drug Res 67: 221-238.
6. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, et al. (2012) MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122: 2884-2897.
7. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
8. Hsu SH, Wang B, Kota J, Yu J, Costinean S, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122: 2871-2883.
9. Wen J, Friedman JR (2012) miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest 122: 2773-2776.
10. Yang YM, Seo SY, Kim TH, Kim SG (2012) Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 56: 2209-2220.
11. Li J, Ghazwani M, Zhang Y, Lu J, Li J, et al. (2013) miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol 58: 522-528.
12. Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, et al. (2013) Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol 58: 234-239.
13. Waidmann O, Koberle V, Brunner F, Zeuzem S, Piiper A, et al. (2012) Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One 7: e45652.
14. Fukuhara T, Matsuura Y (2013) Role of miR-122 and lipid metabolism in HCV infection. J Gastroenterol 48: 169-176.
15. Yoshikawa T, Takata A, Otsuka M, Kishikawa T, Kojima K, et al. (2012) Silencing of microRNA-122 enhances interferon-alpha signaling in the liver through regulating SOCS3 promoter methylation. Sci Rep 2: 637.
16. Bai S, Nasser MW, Wang B, Hsu SH, Datta J, et al. (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284: 32015-32027.
17. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
18. Hsu SH, Wang B, Kutay H, Bid H, Shreve J, et al. (2013) Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol 183: 1719-1730.
19. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, et al. (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678. (Pubitemid 44521987)
20. Zeisel MB, Pfeffer S, Baumert TF (2013) miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo. J Hepatol 58: 821-823.
21. Li C, Wang Y, Wang S, Wu B, Hao J, et al. (2013) Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol 87: 2193-2205.
22. Ma L, Liu J, Shen J, Liu L, Wu J, et al. (2010) Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9: 554-561.
23. Nassirpour R, Mehta PP, Yin MJ (2013) miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3. PLoS One 8: e79655.
24. Yang F, Zhang L, Wang F, Wang Y, Huo XS, et al. (2011) Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia 13: 590-600.
25. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, et al. (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69: 5761-5767.
26. Xu Y, Xia F, Ma L, Shan J, Shen J, et al. (2011) MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett 310: 160-169.
27. Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, et al. (2011) MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2: 338.
28. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, et al. (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
29. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
30. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142. (Pubitemid 43278296)
31. Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33.
32. Tzur G, Levy A, Meiri E, Barad O, Spector Y, et al. (2008) MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS One 3: e3726.
33. Tiscornia G, Singer O, Verma IM (2006) Production and purification of lentiviral vectors. Nat Protoc 1: 241-245.
34. Shi JW, Liu W, Zhang TT, Wang SC, Lin XL, et al. (2013) The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation. Cell Cycle 12: 1119-1127.
35. Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, et al. (2011) Positive regulation of hepatic miR-122 expression by HNF4alpha. J Hepatol 55: 602-611.
36. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, et al. (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047. (Pubitemid 38428943)
37. Ning BF, Ding J, Yin C, Zhong W, Wu K, et al. (2010) Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 70: 7640-7651.
38. Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, et al. (2011) The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4alpha. Hepatology 53: 2063-2074.
39. Spath GF, Weiss MC (1998) Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 140: 935-946. (Pubitemid 28141230)
40. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289.
41. Cheng IK, Tsang BC, Lai KP, Ching AK, Chan AW, et al. (2012) GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J Pathol.
42. Fukui K, Tamura S, Wada A, Kamada Y, Sawai Y, et al. (2006) Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 627-633. (Pubitemid 44310328)
43. Gou L, Wang W, Tong A, Yao Y, Zhou Y, et al. (2011) Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma. J Mol Med (Berl) 89: 817-827.
44. Grise F, Bidaud A, Moreau V (2009) Rho GTPases in hepatocellular carcinoma. Biochim Biophys Acta 1795: 137-151.
45. Hu T, Guo H, Wang W, Yu S, Han L, et al. (2013) Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma. Oncol Rep 30: 1707-1714.
46. Li XR, Ji F, Ouyang J, Wu W, Qian LY, et al. (2006) Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 32: 1130-1134. (Pubitemid 44774395)
47. Struckhoff AP, Rana MK, Worthylake RA (2011) RhoA can lead the way in tumor cell invasion and metastasis. Front Biosci (Landmark Ed) 16: 1915-1926.
48. Wang D, Dou K, Xiang H, Song Z, Zhao Q, et al. (2007) Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol 22: 1916-1920. (Pubitemid 47525048)
49. Xiaorong L, Wei W, Liyuan Q, Kaiyan Y (2008) Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. BMC Cancer 8: 205.
50. Liang L, Li X, Zhang X, Lv Z, He G, et al. (2013) MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology 144: 624-635.
51. Deng XG, Qiu RL, Wu YH, Li ZX, Xie P, et al. (2014) Overexpression of miR-122 promotes the hepatic differentiation and maturation of mouse ESCs through a miR-122/FoxA1/HNF4a-positive feedback loop. Liver Int 34: 281-295.